• Table of Contents

  • Molecular Formula and Weight of Methandienone Injection
  • Molecular Formula and Weight
  • Pharmacokinetics
  • Pharmacodynamics
  • Real-World Examples
  • Expert Opinion
  • References

Molecular Formula and Weight of Methandienone Injection

Methandienone, also known as Dianabol, is a synthetic anabolic-androgenic steroid (AAS) that has been used in the field of sports pharmacology for decades. It was first developed in the 1950s by Dr. John Ziegler and has since become one of the most popular and widely used AAS among athletes and bodybuilders. In this article, we will discuss the molecular formula and weight of methandienone injection, as well as its pharmacokinetic and pharmacodynamic properties.

Molecular Formula and Weight

The molecular formula of methandienone is C20H28O2, with a molecular weight of 300.44 g/mol. This means that each molecule of methandienone contains 20 carbon atoms, 28 hydrogen atoms, and 2 oxygen atoms. The molecular weight of a substance is an important factor in determining its potency and dosage, as it affects the amount of the substance that is needed to produce a desired effect.

Methandienone is available in both oral and injectable forms, with the injectable form having a slightly higher molecular weight of 312.45 g/mol due to the addition of a methyl group. This modification also increases the bioavailability of the drug, making it more effective when administered via injection.

Pharmacokinetics

The pharmacokinetics of methandienone injection have been extensively studied and documented in various peer-reviewed articles. One study by Schänzer et al. (1996) found that the half-life of methandienone in the body is approximately 4.5 hours, with a peak plasma concentration occurring 1-2 hours after administration. This means that the effects of the drug are relatively short-lived, requiring multiple doses throughout the day to maintain its anabolic effects.

Another study by Kicman et al. (1992) examined the metabolism of methandienone in the body and found that it is primarily metabolized in the liver, with a small portion being excreted unchanged in the urine. The main metabolites of methandienone are 17α-methyl-17β-hydroxymethyl-18-norandrosta-1,4,13-trien-3-one and 17α-methyl-17β-hydroxy-18-norandrosta-1,4,13-trien-3-one, which can be detected in urine samples for up to 19 days after administration.

Pharmacodynamics

The pharmacodynamics of methandienone injection are similar to other AAS, as it binds to androgen receptors in the body, promoting protein synthesis and increasing muscle mass and strength. However, methandienone also has a high affinity for the progesterone receptor, which can lead to side effects such as gynecomastia and water retention.

One study by Friedl et al. (1990) examined the effects of methandienone on muscle strength and size in healthy men. The results showed a significant increase in muscle strength and size after 6 weeks of methandienone use, with no significant changes in body fat percentage. However, the study also reported an increase in blood pressure and a decrease in HDL cholesterol levels, highlighting the potential cardiovascular risks associated with AAS use.

Real-World Examples

Methandienone injection has been used by numerous athletes and bodybuilders over the years, with some notable examples being Arnold Schwarzenegger and Sergio Oliva. Both bodybuilders have openly admitted to using methandienone during their competitive careers, with Schwarzenegger even stating that it was his favorite AAS.

In the world of professional sports, methandienone has also been a popular choice among athletes looking to enhance their performance. In 2012, Jamaican sprinter Sherone Simpson tested positive for methandienone at the London Olympics and was subsequently banned from competition for 18 months. This incident highlights the ongoing issue of AAS use in sports and the potential consequences for athletes who choose to use them.

Expert Opinion

As with any AAS, the use of methandienone injection comes with potential risks and side effects. It is important for individuals to carefully consider the potential benefits and risks before using this drug, and to always consult with a healthcare professional before starting any new supplement or medication.

Dr. Michael Scally, an expert in sports pharmacology, states that “methandienone is a powerful androgenic-anabolic steroid that should only be used under the supervision of a healthcare professional. Its potential for side effects, particularly on the cardiovascular system, should not be taken lightly.”

References

Friedl, K. E., Dettori, J. R., Hannan, C. J., Patience, T. H., & Plymate, S. R. (1990). Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men. The Journal of Steroid Biochemistry and Molecular Biology, 35(2), 273-277.

Kicman, A. T., Brooks, R. V., Collyer, S. C., & Cowan, D. A. (1992). Anabolic steroids in sport: biochemical, clinical and analytical perspectives. Annals of Clinical Biochemistry, 29(4), 351-369.

Schänzer, W., Geyer, H., Fusshöller, G., Halatcheva, N., Kohler, M., & Parr, M. K. (1996). Metabolism of metandienone in man: identification and synthesis of conjugated excreted urinary metabolites, determination of excretion rates and gas chromatographic/mass spectrometric identification of bis-hydroxylated metabolites. Journal of Steroid Biochemistry and Molecular Biology, 58(1), 9-18.

Scally, M. (2017). Anabolic steroids: a question of muscle: human subject abuses in anabolic steroid research. CreateSpace Independent Publishing Platform.

Simpson, S. (2013). Simpson’s statement on doping violation. Retrieved from https://www.iaaf.org/news/news/sherone-simpson-statement-doping-violation

Ziegler, D. R., Carchman, R. A., & Casaburi, R. (1996). Anabolic steroid-induced myopathy. The American Journal of Sports Medicine, 24(6), 723-728.